device-based
Dermadry · tap-water iontophoresis
- Regions
- hand, foot, underarm
- Severity fit
- HDSS 2, HDSS 3, HDSS 4
- Type
- home device or clinic device
Treatment · device-based
Iontophoresis is a device-based treatment that uses a small electrical current passed through tap water to reduce sweating, primarily in the hands and feet. It is one of the oldest documented excessive sweating treatments and is available as both clinic-based and home-use devices.
device-based
The exact mechanism is not fully resolved but is thought to involve reversible obstruction of sweat ducts at the stratum corneum and possible alteration of ion transport in eccrine glands. Effect is local to the treated region and dose-dependent on session duration and current intensity.
Iontophoresis is the most-studied non-drug, non-procedural option for hand and excessive foot sweating. It is typically considered early in the hand/foot order of options — earlier than pills that reduce sweating or Botox in many treatment paths. For underarm disease it is used in selected cases but is anatomically harder to apply than for the hands and feet.
Three home devices dominate the consumer market: Dermadry, Hidrex USA, and the RA Fischer plug-in series. They differ in form factor, current capability (pulsed direct current vs straight direct current, maximum amperage), region coverage (hands, feet, underarm), warranty and replacement parts, and price band (typically $499-$950). None is a clear winner across all use cases; the /compare/dermadry-vs-hidrex-vs-ra-fischer page walks through the structured differences.
A typical loading protocol involves 20-30 minute sessions multiple times per week (often 3-5 sessions weekly) until response is achieved. Maintenance is then tapered to once every 1-3 weeks depending on individual response. Skipping maintenance sessions usually allows sweat rate to return. Home devices make this practical because the user controls the schedule.
Tap water is the standard medium. Some protocols add an sweat-reducing medicine agent (e.g., glycopyrrolate) to the water to enhance effect; this is more common in clinic-administered iontophoresis than home use. Battery-operated and pulsed-current devices may improve tolerability and are easier for some users than direct-current devices.
Iontophoresis is contraindicated for people with implanted electrical devices (pacemakers, defibrillators), pregnancy, and skin breakdown at the treatment site. Mild tingling, erythema, and skin dryness are common. Devices have built-in safety limits on current; user-set current should be advanced gradually to a comfortable level.
Numbers and approved uses on this page link back to their sources governed in anna-pipeline. Each entry below is a packet bound to this treatment.
topical antiperspirant
prescription skin treatment that reduces sweating
prescription skin treatment that reduces sweating
device-based
pill that reduces sweating
pill that reduces sweating
Botox
energy-based procedure
energy-based procedure
surgery